These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 168604)

  • 1. Pharmacologic interaction between cannabinol and delta9-tetrahydrocannabinol.
    Takahashi RN; Karniol IG
    Psychopharmacologia; 1975; 41(3):277-84. PubMed ID: 168604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological interaction between cannabidiol and delta 9-tetrahydrocannabinol.
    Karniol IG; Carlini EA
    Psychopharmacologia; 1973 Oct; 33(1):53-70. PubMed ID: 4358666
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of delta9-tetrahydrocannabinol and cannabinol in man.
    Karniol IG; Shirakawa I; Takahashi RN; Knobel E; Musty RE
    Pharmacology; 1975; 13(6):502-12. PubMed ID: 1221432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Further studies of the aggressive behavior induced by delta9-tetrahydrocannabinol in REM sleep-deprived rats.
    Carlini EA
    Psychopharmacology (Berl); 1977 Jul; 53(2):135-45. PubMed ID: 197557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of marihuana in laboratory animals and in man.
    Carlini EA; Karniol IG; Renault PF; Schuster CR
    Br J Pharmacol; 1974 Feb; 50(2):299-309. PubMed ID: 4609532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The interaction of delta9-tetrahydrocannabinol with cholinomimetic drugs in an agonist-antagonist paradigm.
    Jones BC; Consroe PF; Laird HE
    Eur J Pharmacol; 1976 Aug; 38(2):253-9. PubMed ID: 954840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of interaction between delta9-tetrahydrocannabinol (delta-THC) and cannabidiol (CBD) in aggression, muscle control and body temperature experiments in mice.
    Ham MT; De Jong Y
    Psychopharmacologia; 1975; 41(2):169-74. PubMed ID: 1171491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delta9-THC as a discriminative cue in pigeons: effects of delta8-THC, CBD, and CBN.
    Järbe TU; Henriksson BG; Ohlin GC
    Arch Int Pharmacodyn Ther; 1977 Jul; 228(1):68-72. PubMed ID: 921403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Marihuana-like activity of new synthetic tetrahydrocannabinols.
    Martin BR; Dewey WL; Harris LS; Beckner J
    Pharmacol Biochem Behav; 1975; 3(5):849-53. PubMed ID: 1208625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A behavioural comparison of acute and chronic Delta9-tetrahydrocannabinol and cannabidiol in C57BL/6JArc mice.
    Long LE; Chesworth R; Huang XF; McGregor IS; Arnold JC; Karl T
    Int J Neuropsychopharmacol; 2010 Aug; 13(7):861-76. PubMed ID: 19785914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential neurochemistry and temporal pattern in rats treated orally with delta9-tetrahydrocannabinol for periods up to six months.
    Luthra UL; Rosenkrantz H; Heyman IA; Braude MC
    Toxicol Appl Pharmacol; 1975 May; 32(2):418-31. PubMed ID: 1171540
    [No Abstract]   [Full Text] [Related]  

  • 12. Modification of delta9-THC-actions by cannabinol and cannabidiol in the rat.
    Fernandes M; Schabarek A; Coper H; Hill R
    Psychopharmacologia; 1974; 38(4):329-38. PubMed ID: 4473791
    [No Abstract]   [Full Text] [Related]  

  • 13. Delta 9-Tetrahydrocannabinol, ethanol, and amphetamine as discriminative stimuli-generalization tests with other drugs.
    Bueno OF; Carlini EA; Finkelfarb E; Suzuki JS
    Psychopharmacologia; 1976 Apr; 46(3):235-43. PubMed ID: 951459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antineoplastic activity of cannabinoids.
    Munson AE; Harris LS; Friedman MA; Dewey WL; Carchman RA
    J Natl Cancer Inst; 1975 Sep; 55(3):597-602. PubMed ID: 1159836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of cannabinoids on the abdominal constriction response in mice: within cannabinoid interactions.
    Welburn PJ; Starmer GA; Chesher GB; Jackson DM
    Psychopharmacologia; 1976; 46(1):83-5. PubMed ID: 1257370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delta9-tetrahydrocannabinol methamphetamine interaction in the rabbit.
    Consroe PF; Jones BC; Akins F
    Neuropharmacology; 1975; 14(5-6):377-83. PubMed ID: 1171388
    [No Abstract]   [Full Text] [Related]  

  • 17. Potency trends of Δ9-tetrahydrocannabinol, cannabidiol and cannabinol in cannabis in the Netherlands: 2005-15.
    Niesink RJ; Rigter S; Koeter MW; Brunt TM
    Addiction; 2015 Dec; 110(12):1941-50. PubMed ID: 26234170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mouse-killing and motor activity: effects of chronic delta9-tetrahydrocannabinol and pilocarpine.
    Miczek KA
    Psychopharmacology (Berl); 1976 May; 47(1):59-64. PubMed ID: 986662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of naloxone-induced withdrawal in morphine dependent mice by 1-trans-delta9-tetrahydrocannabinol.
    Bhargava HN
    Eur J Pharmacol; 1976 Mar; 36(1):259-62. PubMed ID: 944134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delta9-tetrahydrocannbinol accounts for the antinociceptive, hypothermic, and cataleptic effects of marijuana in mice.
    Varvel SA; Bridgen DT; Tao Q; Thomas BF; Martin BR; Lichtman AH
    J Pharmacol Exp Ther; 2005 Jul; 314(1):329-37. PubMed ID: 15831444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.